Fighting Methicillin-Resistant Staphylococcus aureus with Targeted Nanoparticles
International Journal of Molecular Sciences · 20.05.2023 · 24 (10) · 9030
DOI: 10.3390/ijms24109030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.05.2023. Verfasst von Stéphanie Andrade und 8 weiteren Autor:innen. Beteiligte Einrichtung: LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias,…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Nanoparticles, Staphylococcal Infections. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, European Regional Development Fund, LABBELS.
Abstract (Originalsprache)
Antimicrobial resistance (AMR) is considered one of the greatest threats to global health. Methicillin-resistant Staphylococcus aureus (MRSA) remains at the core of this threat, accounting for about 90% of S. aureus infections widespread in the community and hospital settings. In recent years, the use of nanoparticles (NPs) has emerged as a promising strategy to treat MRSA infections. NPs can act directly as antibacterial agents via antibiotic-independent activity and/or serve as drug delivery systems (DDSs), releasing loaded antibiotics. Nonetheless, directing NPs to the infection site is fundamental for effective MRSA treatment so that highly concentrated therapeutic agents are delivered to the infection site while directly reducing the toxicity to healthy human cells. This leads to decreased AMR emergence and less disturbance of the individual’s healthy microbiota. Hence, this review compiles and discusses the scientific evidence related to targeted NPs developed for MRSA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.
- ALiCE-Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.
- CEB-Centre of Biological Engineering, University of Minho, 4710-057 Braga, Portugal.
- LABBELS-Associate Laboratory, University of Minho, 4710-057 Braga, Portugal.
ORCID-Profile: Stéphanie Andrade, Maria J Ramalho, Sílvio B Santos, Luís D R Melo, Nuno Guimarães, Nuno F Azevedo, Joana A Loureiro, Maria C Pereira
Förderung
- Fundação para a Ciência e Tecnologia
- European Regional Development Fund
- LABBELS
- Prize Maratona da Saúde for Cancer Research
- FCT/MCTES (PIDDAC)
- LABBELS–Associate Laboratory in Biotechnology, Bioengineering and Microelectromechanical Systems
- Scientific Employment Stimulus-Individual Call
Zitieren
APA
Andrade, S., Ramalho, M. J., Santos, S. B., Melo, L. D. R., Santos, R. S., Guimarães, N., Azevedo, N. F., Loureiro, J. A., & Pereira, M. C. (2023). Fighting Methicillin-Resistant Staphylococcus aureus with Targeted Nanoparticles. International Journal of Molecular Sciences, 24(10), 9030. https://doi.org/10.3390/ijms24109030
Vancouver
Andrade S, Ramalho MJ, Santos SB, Melo LDR, Santos RS, Guimarães N, et al. Fighting Methicillin-Resistant Staphylococcus aureus with Targeted Nanoparticles. International Journal of Molecular Sciences. 2023;24(10):9030. doi:10.3390/ijms24109030
BibTeX
@article{Andrade2023,
author = {Andrade, Stéphanie and Ramalho, Maria J and Santos, Sílvio B and Melo, Luís D R and Santos, Rita S and Guimarães, Nuno and Azevedo, Nuno F and Loureiro, Joana A and Pereira, Maria C},
title = {Fighting Methicillin-Resistant Staphylococcus aureus with Targeted Nanoparticles},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {10},
pages = {9030},
doi = {10.3390/ijms24109030}
}
EUVIMED